Skip to content
akaturk Academic measurement
Sign in Sign up
2025 SJR Q1 JCR Q1 · 7,5 OA 498 matched articles SCIE

Journal detail

Biomedicine and Pharmacotherapy

Publisher
Elsevier Masson s.r.l.
Country
France · Western Europe
Type
journal
ISSN
  • 07533322
  • 19506007
Scopus 2,074 SJR
Scopus Q1 SJR Q
WoS Q1 JCR Q
WoS 7,5 JIF
Scopus 196 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 2,074
  • Quartile Q1
  • H-Index 196
  • Cites/doc 9,84
  • Docs (3y) 5.006
  • Cites (3y) 49.563

Clarivate

Web of Science · JCR · 2024

  • JCR Q Q1
  • JIF 7,5
  • 5Y JIF 7,7
  • JCI 1,62

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

Areas

WoS categories

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 — 2,074 — — — — 196
2024 Q1 Q1 1,775 7,5 7,7 1,62 Q1 169
2023 Q1 Q1 1,493 6,9 6,8 1,56 Q1 169
2022 Q1 Q1 1,366 7,5 6,8 1,62 Q1 169
2021 Q1 Q1 1,194 7,4 6,6 1,59 Q1 169
2020 Q1 Q1 1,323 6,5 6 1,62 Q1 169
2019 Q1 Q1 1,05 4,5 4,4 1,52 Q1 169
2018 — Q1 — 3,7 3,6 1,41 Q1 —
2017 Q1 Q2 0,951 3,5 3,2 1,27 Q1 169
2016 Q2 Q2 0,864 2,8 2,5 — — 169
2015 Q2 Q3 0,81 2,3 2,2 — — 169
2014 Q2 Q3 0,788 2 2,1 — — 169
2013 Q2 Q3 0,769 2,1 2,2 — — 169
2012 Q2 Q3 0,713 2,1 2,2 — — 169
2011 Q2 Q3 0,785 2 2,3 — — 169
2010 Q2 Q2 0,728 2,2 2,3 — — 169
2009 — Q2 — 2,2 2,5 — — —
2008 — Q2 — 2,2 2,3 — — —
2007 — Q3 — 1,4 2,1 — — —
2006 — Q3 — 1,5 — — — —
2005 — Q2 — 2,1 — — — —
2004 — Q2 — 1,8 — — — —
2003 — Q3 — 1,3 — — — —
2002 — Q3 — 1 — — — —
2001 — Q3 — 1,2 — — — —
2000 — Q2 — 1,5 — — — —
1999 — Q3 — 0,9 — — — —
1998 — Q3 — 0,7 — — — —
1997 — Q3 — 0,7 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2024 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 Q1 24/195
2024 PHARMACOLOGY & PHARMACY SCIE Q1 Q1 19/352
2023 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 Q1 22/189
2023 PHARMACOLOGY & PHARMACY SCIE Q1 Q1 15/354
2022 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 Q1 27/136
2022 PHARMACOLOGY & PHARMACY SCIE Q1 Q1 22/278
2021 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 Q1 30/139
2021 PHARMACOLOGY & PHARMACY SCIE Q1 Q1 26/279
2020 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 Q1 27/140
2020 PHARMACOLOGY & PHARMACY SCIE Q1 Q1 25/276
2019 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 Q1 32/139
2019 PHARMACOLOGY & PHARMACY SCIE Q1 Q1 42/271
2018 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q1 46/136
2018 PHARMACOLOGY & PHARMACY SCIE Q1 Q1 62/267
2017 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q1 47/133
2017 PHARMACOLOGY & PHARMACY SCIE Q2 Q1 69/261
2016 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 52/128
2016 PHARMACOLOGY & PHARMACY SCIE Q2 — 108/257
2015 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 64/124
2015 PHARMACOLOGY & PHARMACY SCIE Q3 — 129/255
2014 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 72/123
2014 PHARMACOLOGY & PHARMACY SCIE Q3 — 147/255
2013 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 66/124
2013 PHARMACOLOGY & PHARMACY SCIE Q3 — 143/256
2012 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 69/121
2012 PHARMACOLOGY & PHARMACY SCIE Q3 — 145/261
2011 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 61/112
2011 PHARMACOLOGY & PHARMACY SCIE Q3 — 141/261
2010 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 48/106
2010 PHARMACOLOGY & PHARMACY SCIE Q3 — 131/252
2009 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 40/93
2009 PHARMACOLOGY & PHARMACY SCIE Q3 — 122/237
2008 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 41/83
2008 PHARMACOLOGY & PHARMACY SCIE Q3 — 116/219
2007 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 55/81
2007 PHARMACOLOGY & PHARMACY SCIE Q3 — 141/205
2006 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 47/76
2006 PHARMACOLOGY & PHARMACY SCIE Q3 — 124/199
2005 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 35/72
2005 PHARMACOLOGY & PHARMACY SCIE Q2 — 86/193
2004 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 34/71
2004 PHARMACOLOGY & PHARMACY SCIE Q3 — 95/187
2003 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 43/72
2003 PHARMACOLOGY & PHARMACY SCIE Q3 — 115/185
2002 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 51/74
2002 PHARMACOLOGY & PHARMACY SCIE Q3 — 126/188
2001 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 44/75
2001 PHARMACOLOGY & PHARMACY SCIE Q3 — 112/186
2000 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 34/74
2000 PHARMACOLOGY & PHARMACY SCIE Q2 — 78/181
1999 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 44/76
1999 PHARMACOLOGY & PHARMACY SCIE Q3 — 113/175
1998 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 39/72
1998 PHARMACOLOGY & PHARMACY SCIE Q3 — 122/178
1997 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 38/61
1997 PHARMACOLOGY & PHARMACY SCIE Q3 — 117/157